169. Menkes disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 6 / Drugs : 6 - (DrugBank : 4) / Drug target genes : 9 - Drug target pathways : 14
Menkes disease and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 169 | Menkes disease |
| 170 | Occipital horn syndrome |
| 6 | Parkinson disease |
| 17 | Multiple system atrophy |
| 46 | Malignant rheumatoid arthritis |
| 96 | Crohn disease |
| 5 | Progressive supranuclear palsy |
| 11 | Myasthenia gravis |
| 22 | Moyamoya disease |
| 70 | Spinal stenosis |
| 113 | Muscular dystrophy |
| 118 | Myelomeningocele |
| 2 | Amyotrophic lateral sclerosis |
| 280 | Huge arteriovenous malformation with cervicofacial or limb lesion |
| 215 | Tetralogy of Fallot |
| 288 | Autoimmune acquired coagulation factor deficiency |
| 206 | Fragile X syndrome |
| 8 | Huntington disease |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 57 | Idiopathic dilated cardiomyopathy |
| 210 | Single Ventricle |
| 323 | Aromatic L-amino acid decarboxylase deficiency |
| 226 | Interstitial cystitis with Hunners ulcer |
| 85 | Idiopathic interstitial pneumonia |
| 86 | Pulmonary arterial hypertension |
| 278 | Huge lymphatic malformation with cervicofacial lesion |
| 67 | Polycystic kidney disease |
| 127 | Frontotemporal lobar degeneration |
| 58 | Hypertrophic cardiomyopathy |
| 28 | Systemic amyloidosis |
| 212 | Tricuspid atresia |
| 167 | Marfan syndrome |
| 4 | Primary lateral sclerosis |
| 254 | Porphyria |
| 227 | Osler disease |
| 158 | Tuberous sclerosis |
| 78 | Hypopituitarism |
| 296 | Biliary atresia |
| 21 | Mitochondrial disease |
| 90 | Retinitis pigmentosa |
| 107 | Juvenile idiopathic arthritis |
| 34 | Neurofibromatosis |
| 65 | Primary immunodeficiency |
| 157 | Sturge-Weber syndrome |
| 111 | Congenital myopathy |